CompletedPhase 4

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

China362 participantsStarted 2015-11

Plain-language summary

The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ST-segment elevation AMI within 12 hours of symptom onset Exclusion Criteria: * Contraindications to thrombolysis or PCI * Patients administered a fibrinolytic agent before PCI * Patients enrolled in clinical trials

What they're measuring

Coronary flow using corrected Thrombolysis In Myocardial Infarction Frame Count (cTFC)

Timeframe: At the end of Percutaneous Coronary Intervention procedure

Trial details

NCT IDNCT02131220

SponsorFudan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08

View on ClinicalTrials.gov More Myocardial Infarction trials